FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid, the office said on Tuesday, handing a win to BioNTech (22UAy.DE) and its
In the pan-European dispute over Soliris, Alexion has now suffered another defeat. The UK High Court found that an important patent relating to the active ingredient eculizumab would have to be
EPO, and an infringement suit was dismissed by Munich Regional Court. Today, the Mannheim local division also dismissed the infringement suit relating to the second patent. Dish accuses Aylo of
in 2022 that Eolas' patent was invalid, and the U.S. Court of Appeals for the Federal Circuit affirmed the decision in February, determining that the patent was directed to the abstract concept of
The US Court of Appeals for the Federal Circuit has affirmed the invalidation of a number of claims in a patent owned by telecommunications conglomerate AT&T. The court found that the patent, US
A Patent Trial and Appeal Board (PTAB) ruling that an IBM patent was invalid has been reversed by the US Court of Appeals for the Federal Circuit. IBM’s US patent (7,631,346) covered a method and
Property Administration (CNIPA) issued Invalidation Decision No. 26414 on June 26, 2015, finding that claims 1-5 lacked inventiveness and declaring the entire patent invalid. Dissatisfied with this
Property Administration (CNIPA) issued Invalidation Decision No. 26414 on June 26, 2015, finding that claims 1-5 lacked inventiveness and declaring the entire patent invalid. Dissatisfied with this